Intermediate Density Lipoprotein Cholesterol Measurement [PDF]
The determination of the amount of intermediate density lipoprotein present in a sample.
National Cancer Institute
semanticscholar +3 more sources
Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood [PDF]
Defined as the total cholesterol minus high-density lipoprotein (HDL), non-HDL cholesterol has been increasingly acknowledged as a measure of risk estimation for developing atherosclerotic cardiovascular diseases (ASCVD).
Saeed Shoar +7 more
doaj +2 more sources
Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients [PDF]
Patients with chronic renal failure often have alterations in lipoprotein profile including elevated very-low density lipoprotein (VLDL) and intermediate density lipoprotein (IDL), and reduced high density lipoprotein (HDL) levels. Among these changes, raised IDL has been shown as an independent risk factor for atherosclerosis in hemodialysis patients.
Nishizawa, Yoshiki +4 more
openaire +3 more sources
Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. [PDF]
The relationship between the concentrations of intermediate-density lipoprotein (IDL) and other lipoproteins and the extent of coronary artery disease (CAD) was studied in 182 consecutive patients evaluated by selective coronary cineangiography. On univariate analysis, the extent of CAD correlated significantly and positively with very low density ...
R, Tatami +14 more
openaire +3 more sources
High-quality fish oil has a more favourable effect than oxidised fish oil on intermediate-density lipoprotein and LDL subclasses: a randomised controlled trial [PDF]
Amanda Rundblad +4 more
openalex +2 more sources
Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol
Low-density lipoprotein cholesterol (LDL-C) has been recommended as the primary treatment target on lipid management in coronary heart disease (CHD) patients for past several decades.
Xin Su, Yi Kong, Daoquan Peng
doaj +2 more sources
Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis [PDF]
Katsunori Ikewaki +11 more
openalex +2 more sources
Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes. [PDF]
BACKGROUND The role of lipoprotein disturbances in the development of peripheral vascular disease (PVD) has not been sufficiently clarified. METHODS AND RESULTS The relations among concentrations of intermediate density lipoproteins (IDL), apoprotein (apo) B, apo E, and other ...
M, Sentí +4 more
openaire +3 more sources
Studies on abnormalities in serum intermediate density lipoproteins during maintenance hemodialysis
園部 美弥彦 +8 more
openalex +3 more sources
Mechanism, clinical consequences, and management of dyslipidemia in children with nephrotic syndrome [PDF]
Dyslipidemia in nephrotic syndrome (NS) is often characterized by marked increases in the levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, and other lipoproteins, such as very low-density lipoprotein, intermediate-density ...
Hee Sun Baek
doaj +1 more source

